Listed are Studies supported by InCROM since 2020
(conducted at Heishinkai Medical Corporation sites)

Year Phase No. of Subjects
(Site)		 No. of Subjects
(Protocol Total)		 No. of Visit Study Duration Study Site
2024 IIa
(Clinical Pharmacology)		 12 32 19 10 months OPHAC Hospital
2024 IIb 18 343 12 19 months OCROM Clinic
18 ToCROM Clinic
2023 III 18 240 20 32 months OCROM Clinic
13 ToCROM Clinic
2023 III 27 236 14 26 months OCROM Clinic
13 ToCROM Clinic
2023 III 31 3,000 14 52 months OCROM Clinic
20 ToCROM Clinic
2023 III 29 2,000 15 49 months OCROM Clinic
27 ToCROM Clinic
2023 III 21 330 15 29 months OCROM Clinic
22 ToCROM Clinic
2022 IIb 5 780 24 15 months OCROM Clinic
2 ToCROM Clinic
2022 III 25 2,000 15 49 months OCROM Clinic
25 ToCROM Clinic
2021 III 29 198 14 22 months OCROM Clinic
22 ToCROM Clinic
2021 III 16 348 22 22 months OCROM Clinic
11 ToCROM Clinic
2021 III 12 900 22 18 months OCROM Clinic
2020 IIb 10 315 14 8 months OCROM Clinic
16 ToCROM Clinic
2020 III 22 2,400 22 46 months OCROM Clinic